Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

145.13
+11.818.86%
Post-market: 145.840.7114+0.49%19:59 EDT
Volume:87.32M
Turnover:12.92B
Market Cap:57.94B
PE:-18.12
High:159.47
Open:133.11
Low:132.42
Close:133.32
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.40
T/O Rate:23.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.57
PE(LYR):-19.99

Loading ...

Movement Alert|Moderna, Inc. Falls 5.07% in Regular Trading, Cautious Analyst Expectations Weigh Ahead of Q2 Earnings

Market Focus
·
Jul 24

Barclays Reaffirms Their Hold Rating on Moderna (MRNA)

TIPRANKS
·
Jul 24

Moderna (MRNA) Receives a Hold from Bernstein

TIPRANKS
·
Jul 23

Cboe data shows mixed options sentiment in Moderna with shares down 1.48%

TIPRANKS
·
Jul 23

Biotech Experts Want FDA Drug Reviews Based on Science, not Politics

Reuters
·
Jul 22

What Bundibugyo Ebola Vaccines and Treatments are Under Development

Reuters
·
Jul 22

Moderna Inc. Stock Slides 3.8%, Underperforms Peers

Dow Jones
·
Jul 21

Moderna Says Curevac Broke Agreement by Suing over COVID Vaccine Patents

Reuters
·
Jul 21

Goldman Sachs Adjusts Moderna Price Target to $67 From $49, Maintains Neutral Rating

MT Newswires Live
·
Jul 20

Moderna President Stephen Hoge Disposes of Common Shares Worth $3.61 Million

Reuters
·
Jul 17

Moderna Inc. Stock Sheds 7.5%, Underperforms Peers

Dow Jones
·
Jul 17

Movement Alert|Moderna Falls 5.52% in Regular Trading, Patent Settlement Payment Pressure Sparks Market Concern

Market Focus
·
Jul 16

Stock Track | Moderna Plummets 5.08% Intraday Following $178 Million Patent Settlement Payment

Stock Track
·
Jul 16

Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents

MT Newswires Live
·
Jul 16

Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-targeted Cancer Antigen Therapy in Solid Tumors

THOMSON REUTERS
·
Jul 16

Arbutus Biopharma Corp - Expects to Return up to $230 Mln in Capital to Shareholders

THOMSON REUTERS
·
Jul 16

Moderna Doses First Patient in Phase 1 Trial of Mrna-4200 Cancer Therapy in Solid Tumors

Reuters
·
Jul 16

Sanofi Sues Pfizer, Moderna over COVID Shot Technology

Reuters
·
Jul 15

Decoy Therapeutics Adds Moderna Executive Patricia Gauthier to Board

Reuters
·
Jul 15

Jefferies Adjusts Price Target on Moderna to $60 From $53, Maintains Hold Rating

MT Newswires Live
·
Jul 13